Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umut Demirci

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiencesBala Basak Oven Ustaalioglu, Olcun Umit Unal, Nedim Turan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology StudyDogan Uncu, Ibrahim Vedat Bayoglu, Ulku Yalcintas Arslan, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimensAli Osman Kaya, Ugur Coskun, Mahmut Gumus, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 2, 2013
Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncologyTarkan Yetisyigit, Erkan Arpaci, Erdogan Selcuk Seber, et al.
Oncology Research and Treatment|June 7, 2014
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Olcun U Unal, Ilhan Oztop, Ozan Yazici, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Tugba Kos, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)Onur Esbah, Umut Demirci, Faysal Dane, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
World Journal of Urology|November 5, 2016
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumorsMahmut Gumus, Ahmet Bilici, Hatice Odabas, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancerOnder Tonyali, Ugur Coskun, Nur Sener, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiencesBala Basak Oven Ustaalioglu, Olcun Umit Unal, Nedim Turan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology StudyDogan Uncu, Ibrahim Vedat Bayoglu, Ulku Yalcintas Arslan, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimensAli Osman Kaya, Ugur Coskun, Mahmut Gumus, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 2, 2013
Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncologyTarkan Yetisyigit, Erkan Arpaci, Erdogan Selcuk Seber, et al.
Oncology Research and Treatment|June 7, 2014
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Olcun U Unal, Ilhan Oztop, Ozan Yazici, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Tugba Kos, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 9, 2016
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)Onur Esbah, Umut Demirci, Faysal Dane, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
World Journal of Urology|November 5, 2016
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumorsMahmut Gumus, Ahmet Bilici, Hatice Odabas, et al.
Journal of Cancer Research and Clinical Oncology|August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancerOnder Tonyali, Ugur Coskun, Nur Sener, et al.
Pageof 12